Compare CORT & MSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | MSA |
|---|---|---|
| Founded | 1998 | 1914 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 7.0B |
| IPO Year | 2001 | 1994 |
| Metric | CORT | MSA |
|---|---|---|
| Price | $63.63 | $170.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $142.60 | ★ $205.50 |
| AVG Volume (30 Days) | ★ 1.2M | 295.9K |
| Earning Date | 11-03-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 1.23% |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.13 | ★ 5.57 |
| Revenue | $761,407,000.00 | ★ $1,874,814,000.00 |
| Revenue This Year | $52.09 | $11.56 |
| Revenue Next Year | $44.73 | $8.90 |
| P/E Ratio | $57.37 | ★ $31.67 |
| Revenue Growth | ★ 12.79 | 3.69 |
| 52 Week Low | $28.66 | $153.04 |
| 52 Week High | $126.38 | $208.92 |
| Indicator | CORT | MSA |
|---|---|---|
| Relative Strength Index (RSI) | 20.65 | 42.72 |
| Support Level | $30.24 | $162.79 |
| Resistance Level | $122.93 | $176.38 |
| Average True Range (ATR) | 4.77 | 5.74 |
| MACD | -0.14 | 0.02 |
| Stochastic Oscillator | 1.89 | 27.13 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
MSA Safety Inc makes safety products that are used to protect workers in the oil and gas and mining industries. The company's product offerings include breathing apparatuses, fall protection, portable gas detection systems, industrial head protection, fire and rescue helmets, and fixed gas and flame detection systems, among others. The end markets for its products include the fire service, contractor, industrial, mining, oil and gas, and utilities industries. The company has organized its business into four geographical operating segments that are aggregated into two reportable segments: Americas and International. The majority of its revenue is generated from the Americas segment, which is comprised of the company's operations in Northern North America and Latin America geographies.